fda bpc-157 unapproved new drug panel votes to place popular peptide on compounding list FDA panel backs unapproved peptides

Kybella is a once-and-done procedure that provides permanent results

Another peptide, GHK-Cu, is being studied for potential cosmetic benefits such as for photoaging and hair loss and was added to the Category 1 list (but not for injectable routes of administration)

These sequences were then run through an R script (Supplementary Materials, bash_DADA2 + IDTAXA_workflow_Illumina-PairedEnd_V1V3.R) which trimmed reverse reads to 260 bp, removed forward reads exceeding a maximum expected error of three, and truncated reverse reads exceeding a maximum expected error of six

Reconstitution B: 80 mg vial + 3 mL BAC water (26.7 mg/mL total) more BAC water for larger, easier-to-measure draws

In a statement, Safdar said the tragedy underscores the risks of bypassing the FDA approval process and argued that only stronger enforcement and sound policy, not broader compounding access, can protect patients